3 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 69 points (-0.4%) at 16,384 as of Monday, March 10, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 999 issues advancing vs. 1,928 declining with 160 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Mindray Medical International Limited ADR r ( MR), down 3.3%, DexCom ( DXCM), down 3.1%, Laboratory Corporation of America Holdings ( LH), down 2.4%, Brookdale Senior Living ( BKD), down 2.3% and Alere ( ALR), down 2.3%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. St Jude Medical ( STJ) is one of the companies pushing the Health Services industry lower today. As of noon trading, St Jude Medical is down $0.43 (-0.6%) to $66.64 on average volume. Thus far, 1.2 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $66.21-$67.03 after having opened the day at $66.90 as compared to the previous trading day's close of $67.07.

St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. St Jude Medical has a market cap of $19.3 billion and is part of the health care sector. Shares are up 9.7% year-to-date as of the close of trading on Friday. Currently there are 13 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full St Jude Medical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Intuitive Surgical ( ISRG) is down $3.91 (-0.9%) to $440.07 on light volume. Thus far, 123,776 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 544,100 shares. The stock has ranged in price between $436.61-$444.49 after having opened the day at $443.07 as compared to the previous trading day's close of $443.98.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $17.0 billion and is part of the health care sector. Shares are up 15.7% year-to-date as of the close of trading on Friday. Currently there are 7 analysts that rate Intuitive Surgical a buy, 4 analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Thermo Fisher Scientific ( TMO) is down $0.92 (-0.7%) to $125.75 on average volume. Thus far, 1.0 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.5 million shares. The stock has ranged in price between $125.25-$126.70 after having opened the day at $126.48 as compared to the previous trading day's close of $126.67.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics in the United States and internationally. Thermo Fisher Scientific has a market cap of $49.5 billion and is part of the health care sector. Shares are up 13.8% year-to-date as of the close of trading on Friday. Currently there are 14 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Thermo Fisher Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2